

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.47658067 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.47658067 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.44050182 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.02463136 |
| 5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.58705492 |
| 6 | negative regulation of cell killing (GO:0031342) | 5.48571722 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.48571722 |
| 8 | positive thymic T cell selection (GO:0045059) | 5.32143419 |
| 9 | detection of other organism (GO:0098543) | 5.24356194 |
| 10 | regulation of gamma-delta T cell activation (GO:0046643) | 5.18989138 |
| 11 | response to interleukin-15 (GO:0070672) | 5.03392849 |
| 12 | detection of bacterium (GO:0016045) | 5.01952609 |
| 13 | negative thymic T cell selection (GO:0045060) | 5.01022948 |
| 14 | negative T cell selection (GO:0043383) | 5.00114102 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 4.99616641 |
| 16 | macrophage activation involved in immune response (GO:0002281) | 4.95918955 |
| 17 | response to peptidoglycan (GO:0032494) | 4.73553950 |
| 18 | thymic T cell selection (GO:0045061) | 4.73331991 |
| 19 | detection of external biotic stimulus (GO:0098581) | 4.59341321 |
| 20 | leukocyte aggregation (GO:0070486) | 4.59092635 |
| 21 | detection of molecule of bacterial origin (GO:0032490) | 4.58814844 |
| 22 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.54378301 |
| 23 | positive T cell selection (GO:0043368) | 4.42405481 |
| 24 | interferon-gamma production (GO:0032609) | 4.41003363 |
| 25 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.38912208 |
| 26 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.38358942 |
| 27 | tolerance induction (GO:0002507) | 4.36529926 |
| 28 | T cell selection (GO:0045058) | 4.33918453 |
| 29 | cellular response to interleukin-15 (GO:0071350) | 4.28604844 |
| 30 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.28250570 |
| 31 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.24839177 |
| 32 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.21752848 |
| 33 | neutrophil activation (GO:0042119) | 4.20898568 |
| 34 | respiratory burst (GO:0045730) | 4.18420716 |
| 35 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.17263265 |
| 36 | response to host immune response (GO:0052572) | 4.17263265 |
| 37 | detection of biotic stimulus (GO:0009595) | 4.00168012 |
| 38 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.98262080 |
| 39 | T cell migration (GO:0072678) | 3.98045808 |
| 40 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.97625529 |
| 41 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.93017569 |
| 42 | response to host defenses (GO:0052200) | 3.91044430 |
| 43 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.91044430 |
| 44 | response to host (GO:0075136) | 3.91044430 |
| 45 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.87931082 |
| 46 | granulocyte activation (GO:0036230) | 3.81923578 |
| 47 | B cell receptor signaling pathway (GO:0050853) | 3.80109573 |
| 48 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.74427185 |
| 49 | microglial cell activation (GO:0001774) | 3.65692581 |
| 50 | neutrophil mediated immunity (GO:0002446) | 3.65093900 |
| 51 | NIK/NF-kappaB signaling (GO:0038061) | 3.64995912 |
| 52 | negative regulation of T cell mediated immunity (GO:0002710) | 3.60908666 |
| 53 | regulation of mast cell degranulation (GO:0043304) | 3.57232115 |
| 54 | myeloid cell activation involved in immune response (GO:0002275) | 3.55042801 |
| 55 | macrophage activation (GO:0042116) | 3.53134987 |
| 56 | regulation of B cell differentiation (GO:0045577) | 3.52712252 |
| 57 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.50581336 |
| 58 | negative regulation of interleukin-12 production (GO:0032695) | 3.48715523 |
| 59 | negative regulation of phagocytosis (GO:0050765) | 3.44888868 |
| 60 | germinal center formation (GO:0002467) | 3.43766054 |
| 61 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.43239152 |
| 62 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.43057491 |
| 63 | T cell receptor signaling pathway (GO:0050852) | 3.42908465 |
| 64 | T cell costimulation (GO:0031295) | 3.42703398 |
| 65 | regulation of T cell tolerance induction (GO:0002664) | 3.41932481 |
| 66 | positive regulation of histone deacetylation (GO:0031065) | 3.40728950 |
| 67 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.39066439 |
| 68 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.36325852 |
| 69 | lymphocyte costimulation (GO:0031294) | 3.35684806 |
| 70 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.33500793 |
| 71 | positive regulation of B cell differentiation (GO:0045579) | 3.32938689 |
| 72 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.32304907 |
| 73 | positive regulation of humoral immune response (GO:0002922) | 3.28018093 |
| 74 | regulation of response to interferon-gamma (GO:0060330) | 3.25285134 |
| 75 | regulation of leukocyte degranulation (GO:0043300) | 3.25113912 |
| 76 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.24757267 |
| 77 | leukocyte cell-cell adhesion (GO:0007159) | 3.23949366 |
| 78 | positive regulation of isotype switching (GO:0045830) | 3.23767004 |
| 79 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.19620038 |
| 80 | positive regulation of tolerance induction (GO:0002645) | 3.18328793 |
| 81 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.17095457 |
| 82 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.16721923 |
| 83 | leukocyte degranulation (GO:0043299) | 3.15795500 |
| 84 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.15515292 |
| 85 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.14381077 |
| 86 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.14202396 |
| 87 | myeloid leukocyte mediated immunity (GO:0002444) | 3.09777332 |
| 88 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.09090353 |
| 89 | natural killer cell differentiation (GO:0001779) | 3.08664153 |
| 90 | positive regulation of interleukin-2 production (GO:0032743) | 3.08327213 |
| 91 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.08211377 |
| 92 | positive regulation of mast cell activation (GO:0033005) | 3.07835326 |
| 93 | regulation of regulatory T cell differentiation (GO:0045589) | 3.07820135 |
| 94 | dendritic cell chemotaxis (GO:0002407) | 3.05265354 |
| 95 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.01591402 |
| 96 | dendritic cell migration (GO:0036336) | 3.01457951 |
| 97 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.01297430 |
| 98 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.01016451 |
| 99 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.01016451 |
| 100 | mature B cell differentiation (GO:0002335) | 2.98659296 |
| 101 | negative regulation of innate immune response (GO:0045824) | 2.97663652 |
| 102 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.97425728 |
| 103 | negative regulation of type 2 immune response (GO:0002829) | 2.97183301 |
| 104 | negative regulation of interleukin-6 production (GO:0032715) | 2.95868193 |
| 105 | regulation of mast cell activation (GO:0033003) | 2.95396130 |
| 106 | activated T cell proliferation (GO:0050798) | 2.94886287 |
| 107 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.93114520 |
| 108 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.93021486 |
| 109 | positive regulation of B cell mediated immunity (GO:0002714) | 2.93021486 |
| 110 | B cell mediated immunity (GO:0019724) | 2.91499170 |
| 111 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.91331192 |
| 112 | regulation of regulated secretory pathway (GO:1903305) | 2.87948772 |
| 113 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.86851146 |
| 114 | positive regulation of interferon-alpha production (GO:0032727) | 2.86799573 |
| 115 | endothelial tube morphogenesis (GO:0061154) | 2.84651733 |
| 116 | morphogenesis of an endothelium (GO:0003159) | 2.84651733 |
| 117 | response to type I interferon (GO:0034340) | 2.82584926 |
| 118 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.82435359 |
| 119 | regulation of tolerance induction (GO:0002643) | 2.81761608 |
| 120 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.81420011 |
| 121 | T cell homeostasis (GO:0043029) | 2.80098867 |
| 122 | immunoglobulin mediated immune response (GO:0016064) | 2.79221965 |
| 123 | positive regulation by symbiont of host defense response (GO:0052509) | 2.75360770 |
| 124 | modulation by symbiont of host defense response (GO:0052031) | 2.75360770 |
| 125 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.75360770 |
| 126 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.75360770 |
| 127 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.75360770 |
| 128 | modulation by symbiont of host immune response (GO:0052553) | 2.75360770 |
| 129 | myeloid dendritic cell differentiation (GO:0043011) | 2.73307679 |
| 130 | cellular response to type I interferon (GO:0071357) | 2.71344731 |
| 131 | type I interferon signaling pathway (GO:0060337) | 2.71344731 |
| 132 | positive regulation of immunoglobulin production (GO:0002639) | 2.70794743 |
| 133 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.70681125 |
| 134 | response to protozoan (GO:0001562) | 2.69758340 |
| 135 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.68984955 |
| 136 | response to laminar fluid shear stress (GO:0034616) | 2.68733642 |
| 137 | response to muramyl dipeptide (GO:0032495) | 2.67539410 |
| 138 | lymphocyte homeostasis (GO:0002260) | 2.67230157 |
| 139 | T cell proliferation (GO:0042098) | 2.66251715 |
| 140 | myeloid dendritic cell activation (GO:0001773) | 2.65982402 |
| 141 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.65291077 |
| 142 | natural killer cell activation (GO:0030101) | 2.64997290 |
| 143 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.64932114 |
| 144 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.64932114 |
| 145 | regulation of isotype switching (GO:0045191) | 2.60651460 |
| 146 | cellular extravasation (GO:0045123) | 2.60519220 |
| 147 | positive regulation of DNA recombination (GO:0045911) | 2.58582311 |
| 148 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.58128629 |
| 149 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.57960686 |
| 150 | regulation of B cell mediated immunity (GO:0002712) | 2.57220172 |
| 151 | positive regulation of protein deacetylation (GO:0090312) | 2.56453816 |
| 152 | defense response to protozoan (GO:0042832) | 2.55183994 |
| 153 | positive regulation of lamellipodium assembly (GO:0010592) | 2.55009258 |
| 154 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.55005087 |
| 155 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.54200180 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.48583673 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.34224254 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 4.00354316 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.63027133 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.51643312 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.45580981 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.01946285 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.91715253 |
| 9 | MAF_26560356_Chip-Seq_TH1_Human | 2.76029886 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.75942337 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.60367606 |
| 12 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.59019528 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.53828302 |
| 14 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.51729360 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.47150165 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.47111989 |
| 17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.45393022 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 2.44866453 |
| 19 | UTX_26944678_Chip-Seq_JUKART_Human | 2.43873454 |
| 20 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.31654685 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.28520806 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.27553733 |
| 23 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.27492062 |
| 24 | MYB_26560356_Chip-Seq_TH1_Human | 2.24580089 |
| 25 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.23874498 |
| 26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.18186747 |
| 27 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.17484284 |
| 28 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.15007638 |
| 29 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.14133957 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.13323075 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.11654486 |
| 32 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.06809960 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.98916877 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.96829388 |
| 35 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.93159600 |
| 36 | * MAF_26560356_Chip-Seq_TH2_Human | 1.92209229 |
| 37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90713432 |
| 38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.85920951 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84873646 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.82670350 |
| 41 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.78532738 |
| 42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.68863022 |
| 43 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.63600118 |
| 44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.63406766 |
| 45 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.58790074 |
| 46 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.58340170 |
| 47 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.50790291 |
| 48 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.50344928 |
| 49 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.48746614 |
| 50 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.47882998 |
| 51 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43787687 |
| 52 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.35759637 |
| 53 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32661915 |
| 54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30987106 |
| 55 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.29037659 |
| 56 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27781641 |
| 57 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.25859725 |
| 58 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25385341 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24745723 |
| 60 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.24009859 |
| 61 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21718629 |
| 62 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21031532 |
| 63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.19248314 |
| 64 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.19014604 |
| 65 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.17941337 |
| 66 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.16839991 |
| 67 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.15452046 |
| 68 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15056055 |
| 69 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12120951 |
| 70 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.11194701 |
| 71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10365809 |
| 72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09891034 |
| 73 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07372967 |
| 74 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07234511 |
| 75 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.05039744 |
| 76 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04467264 |
| 77 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03987306 |
| 78 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03346441 |
| 79 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01805849 |
| 80 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01678120 |
| 81 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01124385 |
| 82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.00831630 |
| 83 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.00705043 |
| 84 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00451328 |
| 85 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00244404 |
| 86 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97387849 |
| 87 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97043348 |
| 88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96170024 |
| 89 | ATF3_27146783_Chip-Seq_COLON_Human | 0.96152608 |
| 90 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95655526 |
| 91 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.94295455 |
| 92 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93531040 |
| 93 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91924734 |
| 94 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.91173339 |
| 95 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90907163 |
| 96 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90699219 |
| 97 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90455146 |
| 98 | GATA1_22025678_ChIP-Seq_K562_Human | 0.90368141 |
| 99 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90040929 |
| 100 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.89607632 |
| 101 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.89431966 |
| 102 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88887439 |
| 103 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88515149 |
| 104 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.86302173 |
| 105 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.85443249 |
| 106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.85334319 |
| 107 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85313777 |
| 108 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84952589 |
| 109 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.84532638 |
| 110 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.84360063 |
| 111 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84342703 |
| 112 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.84288571 |
| 113 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.84025422 |
| 114 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83588097 |
| 115 | P68_20966046_ChIP-Seq_HELA_Human | 0.82626657 |
| 116 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.82350423 |
| 117 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81391593 |
| 118 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.81166987 |
| 119 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.80959422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.86030358 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.36690410 |
| 3 | MP0000685_abnormal_immune_system | 3.36057921 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.31103890 |
| 5 | MP0001800_abnormal_humoral_immune | 3.19642047 |
| 6 | MP0003436_decreased_susceptibility_to | 3.15730840 |
| 7 | MP0005387_immune_system_phenotype | 3.15647108 |
| 8 | MP0001790_abnormal_immune_system | 3.15647108 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.97373800 |
| 10 | MP0005671_abnormal_response_to | 2.92617451 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.73108036 |
| 12 | MP0004510_myositis | 2.68823984 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.60300901 |
| 14 | MP0002723_abnormal_immune_serum | 2.53761051 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.47164412 |
| 16 | MP0001819_abnormal_immune_cell | 2.44048249 |
| 17 | MP0002398_abnormal_bone_marrow | 2.37040566 |
| 18 | MP0009785_altered_susceptibility_to | 2.32549353 |
| 19 | MP0008260_abnormal_autophagy | 2.26133910 |
| 20 | MP0005025_abnormal_response_to | 2.26113572 |
| 21 | MP0002405_respiratory_system_inflammati | 2.18170398 |
| 22 | MP0001873_stomach_inflammation | 2.12305214 |
| 23 | MP0009278_abnormal_bone_marrow | 2.12201380 |
| 24 | MP0000716_abnormal_immune_system | 2.11665814 |
| 25 | MP0004947_skin_inflammation | 2.08057637 |
| 26 | MP0002166_altered_tumor_susceptibility | 2.06542718 |
| 27 | MP0010352_gastrointestinal_tract_polyps | 2.03937006 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 2.03622676 |
| 29 | MP0002396_abnormal_hematopoietic_system | 2.00175532 |
| 30 | MP0002419_abnormal_innate_immunity | 2.00017977 |
| 31 | MP0002132_abnormal_respiratory_system | 1.98312213 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.97920603 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.96192494 |
| 34 | MP0002722_abnormal_immune_system | 1.92101886 |
| 35 | MP0006082_CNS_inflammation | 1.86425740 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.85794165 |
| 37 | MP0000703_abnormal_thymus_morphology | 1.82226736 |
| 38 | MP0002277_abnormal_respiratory_mucosa | 1.76299763 |
| 39 | MP0002429_abnormal_blood_cell | 1.76266810 |
| 40 | MP0003724_increased_susceptibility_to | 1.74542958 |
| 41 | MP0003866_abnormal_defecation | 1.70471463 |
| 42 | MP0002006_tumorigenesis | 1.70160452 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.69198735 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.68924383 |
| 45 | MP0001853_heart_inflammation | 1.67996528 |
| 46 | MP0004381_abnormal_hair_follicle | 1.63748261 |
| 47 | MP0002148_abnormal_hypersensitivity_rea | 1.58890332 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.54587784 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.54587784 |
| 50 | MP0005076_abnormal_cell_differentiation | 1.51971224 |
| 51 | MP0008961_abnormal_basal_metabolism | 1.50414868 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.45824709 |
| 53 | MP0000858_altered_metastatic_potential | 1.41253159 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.41052602 |
| 55 | MP0003448_altered_tumor_morphology | 1.38851682 |
| 56 | MP0003566_abnormal_cell_adhesion | 1.36660476 |
| 57 | MP0002933_joint_inflammation | 1.35969002 |
| 58 | MP0000465_gastrointestinal_hemorrhage | 1.33555671 |
| 59 | MP0004883_abnormal_blood_vessel | 1.29500102 |
| 60 | MP0003705_abnormal_hypodermis_morpholog | 1.28300480 |
| 61 | MP0002138_abnormal_hepatobiliary_system | 1.24500835 |
| 62 | MP0005023_abnormal_wound_healing | 1.23040878 |
| 63 | MP0009840_abnormal_foam_cell | 1.22858616 |
| 64 | MP0008469_abnormal_protein_level | 1.16253492 |
| 65 | MP0003453_abnormal_keratinocyte_physiol | 1.09024888 |
| 66 | MP0005310_abnormal_salivary_gland | 1.08447089 |
| 67 | MP0000490_abnormal_crypts_of | 1.07259091 |
| 68 | MP0003091_abnormal_cell_migration | 1.07100222 |
| 69 | MP0005164_abnormal_response_to | 1.05319860 |
| 70 | MP0003191_abnormal_cellular_cholesterol | 1.01217594 |
| 71 | MP0002019_abnormal_tumor_incidence | 1.00971638 |
| 72 | MP0010307_abnormal_tumor_latency | 0.98310681 |
| 73 | MP0003045_fibrosis | 0.97863039 |
| 74 | MP0004858_abnormal_nervous_system | 0.97720722 |
| 75 | MP0004185_abnormal_adipocyte_glucose | 0.94574441 |
| 76 | MP0001851_eye_inflammation | 0.93985716 |
| 77 | MP0009764_decreased_sensitivity_to | 0.92810325 |
| 78 | MP0003690_abnormal_glial_cell | 0.91110403 |
| 79 | MP0005166_decreased_susceptibility_to | 0.87512379 |
| 80 | MP0000609_abnormal_liver_physiology | 0.86450522 |
| 81 | MP0000343_altered_response_to | 0.82007003 |
| 82 | MP0002998_abnormal_bone_remodeling | 0.81979088 |
| 83 | MP0003828_pulmonary_edema | 0.79938813 |
| 84 | MP0010234_abnormal_vibrissa_follicle | 0.78499698 |
| 85 | MP0003172_abnormal_lysosome_physiology | 0.78203370 |
| 86 | MP0003221_abnormal_cardiomyocyte_apopto | 0.77734404 |
| 87 | MP0005058_abnormal_lysosome_morphology | 0.76778555 |
| 88 | MP0000604_amyloidosis | 0.76259488 |
| 89 | MP0009763_increased_sensitivity_to | 0.71127397 |
| 90 | MP0003279_aneurysm | 0.68570164 |
| 91 | MP0001663_abnormal_digestive_system | 0.67612701 |
| 92 | MP0000733_abnormal_muscle_development | 0.67529577 |
| 93 | MP0003075_altered_response_to | 0.67090953 |
| 94 | MP0000249_abnormal_blood_vessel | 0.66963804 |
| 95 | MP0003795_abnormal_bone_structure | 0.65563530 |
| 96 | MP0008004_abnormal_stomach_pH | 0.64940853 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.62428450 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.61077832 |
| 99 | MP0005075_abnormal_melanosome_morpholog | 0.59953383 |
| 100 | MP0000477_abnormal_intestine_morphology | 0.58734794 |
| 101 | MP0005451_abnormal_body_composition | 0.57864686 |
| 102 | MP0000598_abnormal_liver_morphology | 0.57451558 |
| 103 | MP0000350_abnormal_cell_proliferation | 0.57058541 |
| 104 | MP0008874_decreased_physiological_sensi | 0.56909805 |
| 105 | MP0001958_emphysema | 0.55764512 |
| 106 | MP0005377_hearing/vestibular/ear_phenot | 0.55368613 |
| 107 | MP0003878_abnormal_ear_physiology | 0.55368613 |
| 108 | MP0005621_abnormal_cell_physiology | 0.54857183 |
| 109 | MP0003077_abnormal_cell_cycle | 0.53900799 |
| 110 | MP0002086_abnormal_extraembryonic_tissu | 0.53824435 |
| 111 | MP0000015_abnormal_ear_pigmentation | 0.53644505 |
| 112 | MP0002133_abnormal_respiratory_system | 0.53272140 |
| 113 | MP0005388_respiratory_system_phenotype | 0.53272140 |
| 114 | MP0005167_abnormal_blood-brain_barrier | 0.52940875 |
| 115 | MP0003656_abnormal_erythrocyte_physiolo | 0.52934134 |
| 116 | MP0001986_abnormal_taste_sensitivity | 0.52838625 |
| 117 | MP0003806_abnormal_nucleotide_metabolis | 0.51643878 |
| 118 | MP0005390_skeleton_phenotype | 0.51315801 |
| 119 | MP0009931_abnormal_skin_appearance | 0.51018427 |
| 120 | MP0004130_abnormal_muscle_cell | 0.50838638 |
| 121 | MP0008873_increased_physiological_sensi | 0.49940142 |
| 122 | MP0000371_diluted_coat_color | 0.49303498 |
| 123 | MP0002877_abnormal_melanocyte_morpholog | 0.48997112 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.53727928 |
| 2 | Recurrent bronchitis (HP:0002837) | 4.19244172 |
| 3 | Chronic otitis media (HP:0000389) | 4.11222050 |
| 4 | Nasal polyposis (HP:0100582) | 4.09988626 |
| 5 | Recurrent fungal infections (HP:0002841) | 4.02062346 |
| 6 | T lymphocytopenia (HP:0005403) | 3.96320330 |
| 7 | Abnormality of the nasal mucosa (HP:0000433) | 3.93577286 |
| 8 | Recurrent viral infections (HP:0004429) | 3.90398491 |
| 9 | Hypochromic microcytic anemia (HP:0004840) | 3.87453844 |
| 10 | Keratoconjunctivitis sicca (HP:0001097) | 3.85453042 |
| 11 | Abnormality of T cell number (HP:0011839) | 3.80179645 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.75405669 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.74173007 |
| 14 | Stomatitis (HP:0010280) | 3.64112168 |
| 15 | IgM deficiency (HP:0002850) | 3.59448732 |
| 16 | Urticaria (HP:0001025) | 3.56243073 |
| 17 | Myositis (HP:0100614) | 3.56167835 |
| 18 | Keratoconjunctivitis (HP:0001096) | 3.51215070 |
| 19 | Hypochromic anemia (HP:0001931) | 3.51133271 |
| 20 | Cellulitis (HP:0100658) | 3.47845849 |
| 21 | Pustule (HP:0200039) | 3.46611379 |
| 22 | Recurrent abscess formation (HP:0002722) | 3.46200629 |
| 23 | Autoimmune thrombocytopenia (HP:0001973) | 3.42436980 |
| 24 | Panhypogammaglobulinemia (HP:0003139) | 3.41002967 |
| 25 | Abnormality of T cells (HP:0002843) | 3.40750778 |
| 26 | Spontaneous hematomas (HP:0007420) | 3.31527028 |
| 27 | Abnormality of the fingertips (HP:0001211) | 3.30301327 |
| 28 | Papilloma (HP:0012740) | 3.27237703 |
| 29 | Verrucae (HP:0200043) | 3.27237703 |
| 30 | Mediastinal lymphadenopathy (HP:0100721) | 3.26553291 |
| 31 | Inflammation of the large intestine (HP:0002037) | 3.22420227 |
| 32 | Peritonitis (HP:0002586) | 3.19960620 |
| 33 | Agammaglobulinemia (HP:0004432) | 3.19938587 |
| 34 | Gastrointestinal inflammation (HP:0004386) | 3.19665559 |
| 35 | Colitis (HP:0002583) | 3.15669759 |
| 36 | Meningitis (HP:0001287) | 3.14616730 |
| 37 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.07268746 |
| 38 | Recurrent cutaneous fungal infections (HP:0011370) | 3.07268746 |
| 39 | Vasculitis (HP:0002633) | 3.05253985 |
| 40 | Episodic fever (HP:0001954) | 3.04558392 |
| 41 | Recurrent bacterial skin infections (HP:0005406) | 3.02345468 |
| 42 | Increased IgE level (HP:0003212) | 3.01507022 |
| 43 | Interstitial pulmonary disease (HP:0006530) | 3.00946204 |
| 44 | Gastrointestinal stroma tumor (HP:0100723) | 2.85813701 |
| 45 | Emphysema (HP:0002097) | 2.84727009 |
| 46 | Anorexia (HP:0002039) | 2.77841625 |
| 47 | Abnormality of T cell physiology (HP:0011840) | 2.74296959 |
| 48 | Increased density of long bones (HP:0006392) | 2.73370894 |
| 49 | Lymphopenia (HP:0001888) | 2.72274060 |
| 50 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.66702813 |
| 51 | Increased IgM level (HP:0003496) | 2.61509395 |
| 52 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.60161539 |
| 53 | Orchitis (HP:0100796) | 2.59492871 |
| 54 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.57688310 |
| 55 | Recurrent skin infections (HP:0001581) | 2.55234218 |
| 56 | Chronic obstructive pulmonary disease (HP:0006510) | 2.54913973 |
| 57 | Obstructive lung disease (HP:0006536) | 2.54913973 |
| 58 | IgA deficiency (HP:0002720) | 2.46150836 |
| 59 | Amyloidosis (HP:0011034) | 2.46081894 |
| 60 | Abnormality of the peritoneum (HP:0002585) | 2.45789011 |
| 61 | Microcytic anemia (HP:0001935) | 2.45359546 |
| 62 | Pulmonary infiltrates (HP:0002113) | 2.43260319 |
| 63 | Sepsis (HP:0100806) | 2.41992368 |
| 64 | Arterial thrombosis (HP:0004420) | 2.40187758 |
| 65 | Combined immunodeficiency (HP:0005387) | 2.40105036 |
| 66 | Retrobulbar optic neuritis (HP:0100654) | 2.39805363 |
| 67 | Optic neuritis (HP:0100653) | 2.39805363 |
| 68 | Basal cell carcinoma (HP:0002671) | 2.39024903 |
| 69 | Hematochezia (HP:0002573) | 2.36787381 |
| 70 | Recurrent sinusitis (HP:0011108) | 2.36385206 |
| 71 | Abnormal platelet volume (HP:0011876) | 2.34440918 |
| 72 | Chest pain (HP:0100749) | 2.33628266 |
| 73 | Cerebral aneurysm (HP:0004944) | 2.32971050 |
| 74 | Petechiae (HP:0000967) | 2.31241000 |
| 75 | Abnormality of the pleura (HP:0002103) | 2.30856958 |
| 76 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.28518913 |
| 77 | Hemoptysis (HP:0002105) | 2.28452437 |
| 78 | Gangrene (HP:0100758) | 2.28147940 |
| 79 | Prolonged bleeding time (HP:0003010) | 2.26437218 |
| 80 | Slow saccadic eye movements (HP:0000514) | 2.25832963 |
| 81 | Bronchitis (HP:0012387) | 2.25608556 |
| 82 | Restrictive lung disease (HP:0002091) | 2.23552096 |
| 83 | Abnormality of macrophages (HP:0004311) | 2.22465293 |
| 84 | Myocardial infarction (HP:0001658) | 2.21974096 |
| 85 | Chronic sinusitis (HP:0011109) | 2.21203356 |
| 86 | Thrombocytosis (HP:0001894) | 2.20877967 |
| 87 | Osteomyelitis (HP:0002754) | 2.20352142 |
| 88 | Joint swelling (HP:0001386) | 2.18629436 |
| 89 | Abnormality of the endocardium (HP:0004306) | 2.17660633 |
| 90 | Glomerulopathy (HP:0100820) | 2.17479440 |
| 91 | Subacute progressive viral hepatitis (HP:0006572) | 2.16788237 |
| 92 | Epistaxis (HP:0000421) | 2.16718529 |
| 93 | Leukocytosis (HP:0001974) | 2.16113316 |
| 94 | Pulmonary embolism (HP:0002204) | 2.14378358 |
| 95 | Premature loss of primary teeth (HP:0006323) | 2.12614100 |
| 96 | IgG deficiency (HP:0004315) | 2.11601502 |
| 97 | Gingival bleeding (HP:0000225) | 2.10696986 |
| 98 | Gastrointestinal infarctions (HP:0005244) | 2.09837881 |
| 99 | Severe combined immunodeficiency (HP:0004430) | 2.09504833 |
| 100 | Encephalitis (HP:0002383) | 2.08993683 |
| 101 | Abnormality of B cell number (HP:0010975) | 2.08634960 |
| 102 | B lymphocytopenia (HP:0010976) | 2.08634960 |
| 103 | Metaphyseal cupping (HP:0003021) | 2.07842823 |
| 104 | Frequent falls (HP:0002359) | 2.07216770 |
| 105 | Viral hepatitis (HP:0006562) | 2.06745558 |
| 106 | Acne (HP:0001061) | 2.05201756 |
| 107 | Eosinophilia (HP:0001880) | 2.05129217 |
| 108 | Skin ulcer (HP:0200042) | 2.02837789 |
| 109 | Polycythemia (HP:0001901) | 2.02574651 |
| 110 | Abnormality of the pericardium (HP:0001697) | 2.01435840 |
| 111 | Hepatosplenomegaly (HP:0001433) | 2.00284864 |
| 112 | Gingivitis (HP:0000230) | 1.98994400 |
| 113 | Impaired platelet aggregation (HP:0003540) | 1.98929296 |
| 114 | Abnormal platelet function (HP:0011869) | 1.98929296 |
| 115 | Lymphoma (HP:0002665) | 1.97270149 |
| 116 | Persistence of primary teeth (HP:0006335) | 1.96853136 |
| 117 | Keratitis (HP:0000491) | 1.96080189 |
| 118 | Increased mean platelet volume (HP:0011877) | 1.95798907 |
| 119 | Acute hepatic failure (HP:0006554) | 1.94363755 |
| 120 | Purpura (HP:0000979) | 1.92656644 |
| 121 | Abnormality of eosinophils (HP:0001879) | 1.91157231 |
| 122 | Hypermelanotic macule (HP:0001034) | 1.91130405 |
| 123 | Periodontitis (HP:0000704) | 1.91046843 |
| 124 | Loss of speech (HP:0002371) | 1.87833148 |
| 125 | Aortic aneurysm (HP:0004942) | 1.83940850 |
| 126 | Increased serum ferritin (HP:0003281) | 1.83573446 |
| 127 | Hyperacusis (HP:0010780) | 1.83157619 |
| 128 | Recurrent pneumonia (HP:0006532) | 1.80423824 |
| 129 | Chronic diarrhea (HP:0002028) | 1.80280792 |
| 130 | Vertigo (HP:0002321) | 1.79664576 |
| 131 | Thyroiditis (HP:0100646) | 1.79019579 |
| 132 | Hypergammaglobulinemia (HP:0010702) | 1.78593666 |
| 133 | Ulnar bowing (HP:0003031) | 1.76176544 |
| 134 | Skin rash (HP:0000988) | 1.76016623 |
| 135 | Granulocytopenia (HP:0001913) | 1.75788260 |
| 136 | Cheilitis (HP:0100825) | 1.74303480 |
| 137 | Arthralgia (HP:0002829) | 1.73237111 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.07220379 |
| 2 | MAP3K10 | 3.06336230 |
| 3 | TRIB3 | 2.86931729 |
| 4 | TXK | 2.69434553 |
| 5 | EEF2K | 2.65984590 |
| 6 | PRPF4B | 2.55912507 |
| 7 | STK10 | 2.53154915 |
| 8 | JAK3 | 2.50448836 |
| 9 | ERN1 | 2.50113318 |
| 10 | TYK2 | 2.38710664 |
| 11 | FGFR4 | 2.38051904 |
| 12 | PKN2 | 2.34309248 |
| 13 | GRK6 | 2.32474956 |
| 14 | ZAP70 | 2.12659186 |
| 15 | JAK1 | 1.96428297 |
| 16 | ITK | 1.95395011 |
| 17 | EPHB1 | 1.86923725 |
| 18 | MAP3K3 | 1.86874861 |
| 19 | LRRK2 | 1.83404983 |
| 20 | TBK1 | 1.80778981 |
| 21 | MAP3K14 | 1.78720614 |
| 22 | CDK12 | 1.77228916 |
| 23 | IKBKE | 1.69692021 |
| 24 | FGFR3 | 1.62426671 |
| 25 | CSK | 1.56280682 |
| 26 | MAP3K13 | 1.53716476 |
| 27 | SMG1 | 1.51269868 |
| 28 | BTK | 1.47395551 |
| 29 | SIK2 | 1.46985424 |
| 30 | MAP2K3 | 1.42260600 |
| 31 | HCK | 1.36376258 |
| 32 | TTN | 1.32209969 |
| 33 | TAOK1 | 1.32106479 |
| 34 | ALK | 1.29823332 |
| 35 | SYK | 1.26845382 |
| 36 | BLK | 1.25597914 |
| 37 | MARK3 | 1.25451660 |
| 38 | YES1 | 1.23547162 |
| 39 | LCK | 1.23528324 |
| 40 | TGFBR2 | 1.17672345 |
| 41 | PTK6 | 1.17375669 |
| 42 | IKBKB | 1.12963665 |
| 43 | TAOK2 | 1.10004015 |
| 44 | IRAK2 | 1.09478890 |
| 45 | EPHA3 | 1.09327475 |
| 46 | JAK2 | 1.08816836 |
| 47 | PIM1 | 1.06240391 |
| 48 | IRAK1 | 1.05923615 |
| 49 | MAP3K7 | 1.04025376 |
| 50 | RIPK4 | 1.02185268 |
| 51 | RPS6KA4 | 1.00811098 |
| 52 | KIT | 0.99519353 |
| 53 | FES | 0.99098351 |
| 54 | TEC | 0.98168763 |
| 55 | CSF1R | 0.97185336 |
| 56 | PRKCH | 0.95360154 |
| 57 | NLK | 0.90508090 |
| 58 | CHUK | 0.90130310 |
| 59 | CLK1 | 0.88750434 |
| 60 | SIK1 | 0.87707660 |
| 61 | IRAK3 | 0.87484270 |
| 62 | CDK4 | 0.87465069 |
| 63 | MATK | 0.84029862 |
| 64 | KSR2 | 0.83947866 |
| 65 | RIPK1 | 0.82976670 |
| 66 | MAP3K6 | 0.82250380 |
| 67 | PDPK1 | 0.80989469 |
| 68 | MAP3K2 | 0.74938815 |
| 69 | IRAK4 | 0.71237702 |
| 70 | CDC42BPA | 0.69778407 |
| 71 | BMX | 0.67939048 |
| 72 | CDK19 | 0.65326968 |
| 73 | DYRK1B | 0.64324326 |
| 74 | MAP3K8 | 0.64173245 |
| 75 | STK38 | 0.63404029 |
| 76 | RET | 0.63368883 |
| 77 | FYN | 0.63287218 |
| 78 | TAOK3 | 0.63017467 |
| 79 | PRKD2 | 0.62734467 |
| 80 | MAP2K4 | 0.61453917 |
| 81 | NEK2 | 0.61407182 |
| 82 | PRKCQ | 0.61064853 |
| 83 | PDK1 | 0.59616221 |
| 84 | MAP3K11 | 0.59510676 |
| 85 | TNK2 | 0.58996203 |
| 86 | CDK6 | 0.57355140 |
| 87 | HIPK2 | 0.57070739 |
| 88 | LYN | 0.56625372 |
| 89 | STK11 | 0.56124883 |
| 90 | KDR | 0.55448647 |
| 91 | NME2 | 0.55176202 |
| 92 | RAF1 | 0.53559883 |
| 93 | TYRO3 | 0.53381505 |
| 94 | PRKG2 | 0.51501072 |
| 95 | PTK2B | 0.51130799 |
| 96 | KSR1 | 0.49668577 |
| 97 | RPS6KC1 | 0.49308006 |
| 98 | RPS6KL1 | 0.49308006 |
| 99 | MAP3K1 | 0.49203159 |
| 100 | PDGFRB | 0.48849037 |
| 101 | CAMKK1 | 0.47939699 |
| 102 | DMPK | 0.47908752 |
| 103 | MAP3K5 | 0.46669746 |
| 104 | TGFBR1 | 0.46296044 |
| 105 | CDK9 | 0.45761542 |
| 106 | EGFR | 0.44220890 |
| 107 | MARK2 | 0.44101554 |
| 108 | MTOR | 0.43548781 |
| 109 | BMPR2 | 0.43150829 |
| 110 | MELK | 0.42947785 |
| 111 | MAPK11 | 0.42874779 |
| 112 | MAPK7 | 0.42140770 |
| 113 | MAPKAPK2 | 0.40659838 |
| 114 | FLT3 | 0.39727614 |
| 115 | RPS6KB2 | 0.36574280 |
| 116 | FGR | 0.35974795 |
| 117 | MAPK12 | 0.35304233 |
| 118 | MAP3K9 | 0.35138994 |
| 119 | PRKCZ | 0.34482601 |
| 120 | TESK2 | 0.33972728 |
| 121 | MAPK4 | 0.33476182 |
| 122 | MAP2K6 | 0.33420286 |
| 123 | BRD4 | 0.31949701 |
| 124 | STK4 | 0.31433111 |
| 125 | ABL1 | 0.31237629 |
| 126 | SGK3 | 0.31002363 |
| 127 | SIK3 | 0.30834797 |
| 128 | CAMK1D | 0.29445670 |
| 129 | PRKD1 | 0.27584335 |
| 130 | RPS6KA6 | 0.27569826 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.63508835 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.83640800 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.62566829 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.50057645 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.41953357 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.37845861 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.35417344 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.17696030 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.11297794 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.93328765 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.88262830 |
| 12 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.83296580 |
| 13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.81325122 |
| 14 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.75440685 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.75290128 |
| 16 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.68403546 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.68073668 |
| 18 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.64095199 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.59079806 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.56095625 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.53587538 |
| 22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.52863078 |
| 23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.50936598 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.50556588 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.45684004 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.44302910 |
| 27 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.41748558 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.39800321 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.37827564 |
| 30 | Hepatitis B_Homo sapiens_hsa05161 | 1.37600706 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.36943904 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.36034268 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.35662755 |
| 34 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.30687875 |
| 35 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.30421223 |
| 36 | Phagosome_Homo sapiens_hsa04145 | 1.29872450 |
| 37 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.29259470 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.26557617 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.25878335 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 1.25429728 |
| 41 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.23929851 |
| 42 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.20225526 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 1.14635640 |
| 44 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.12944217 |
| 45 | Asthma_Homo sapiens_hsa05310 | 1.09717398 |
| 46 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.07908832 |
| 47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.07601068 |
| 48 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.04800815 |
| 49 | Malaria_Homo sapiens_hsa05144 | 1.02862951 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 1.02801383 |
| 51 | Pertussis_Homo sapiens_hsa05133 | 1.00355487 |
| 52 | HTLV-I infection_Homo sapiens_hsa05166 | 0.98313164 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.97895226 |
| 54 | Other glycan degradation_Homo sapiens_hsa00511 | 0.95509745 |
| 55 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.95494631 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 0.92075471 |
| 57 | Insulin resistance_Homo sapiens_hsa04931 | 0.92041147 |
| 58 | Colorectal cancer_Homo sapiens_hsa05210 | 0.87602339 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86586981 |
| 60 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85483433 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84219534 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82540282 |
| 63 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.76712563 |
| 64 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.76458834 |
| 65 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76175569 |
| 66 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75677565 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.74771330 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.73539755 |
| 69 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.70731109 |
| 70 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69377883 |
| 71 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.69349134 |
| 72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69272163 |
| 73 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.68847659 |
| 74 | Endometrial cancer_Homo sapiens_hsa05213 | 0.68173293 |
| 75 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.67067005 |
| 76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66934245 |
| 77 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.66473292 |
| 78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.64097174 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63310559 |
| 80 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.63004773 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.62690734 |
| 82 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.62603777 |
| 83 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61212936 |
| 84 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60570362 |
| 85 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58485063 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57817378 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57509497 |
| 88 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.56778940 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.56580904 |
| 90 | Lysine degradation_Homo sapiens_hsa00310 | 0.54792567 |
| 91 | Glioma_Homo sapiens_hsa05214 | 0.53757122 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53073987 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51908386 |
| 94 | Lysosome_Homo sapiens_hsa04142 | 0.51850893 |
| 95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51161938 |
| 96 | Thyroid cancer_Homo sapiens_hsa05216 | 0.50448622 |
| 97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49959053 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49860796 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49809586 |
| 100 | Prostate cancer_Homo sapiens_hsa05215 | 0.48610002 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47718154 |
| 102 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47426979 |
| 103 | Focal adhesion_Homo sapiens_hsa04510 | 0.45243638 |
| 104 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45183799 |
| 105 | Adherens junction_Homo sapiens_hsa04520 | 0.45065663 |
| 106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44533225 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43162809 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43032309 |
| 109 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.40383763 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38052157 |
| 111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36616376 |
| 112 | Pathways in cancer_Homo sapiens_hsa05200 | 0.34961535 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34432092 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33634432 |
| 115 | Bladder cancer_Homo sapiens_hsa05219 | 0.33586900 |

